Transgene SA Profile Avatar - Palmy Investing

Transgene SA

Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clini…

Biotechnology
FR, Illkirch-Graffenstaden [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Transgene SA can't present it's latest revenue by geo. area

Revenue By Geographic Areas

Transgene SA can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

Transgene SA can't present revenue by segment

Historical Revenue By Geographic Area

Last 3Y, in mil. USD

Transgene SA can't present revenue by geo. area

End of TNG.PA's Analysis
CIK: - CUSIP: - ISIN: FR0005175080 LEI: - UEI: -
Secondary Listings
TNG.PA has no secondary listings inside our databases.